William Scott Durall - 15 Feb 2022 Form 4 Insider Report for SURGALIGN HOLDINGS, INC.

Role
Chief Commercial Officer
Signature
by Jessica Rumschlag as attorney in fact
Issuer symbol
N/A
Transactions as of
15 Feb 2022
Net transactions value
+$99,973
Form type
4
Filing time
16 Feb 2022, 10:44:41 UTC
Previous filing
10 May 2021
Next filing
01 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRGA Common Stock Purchase $99,956 +217,391 +33% $0.4598 878,778 15 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRGA Warrant (right to buy) Purchase $16.3 +163,043 +54% $0.000100* 465,462 15 Feb 2022 Common Stock 163,043 $0.6000 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Total shares includes 17,985 shares purchased under the Company's Employee Stock Purchase Plan on December 31, 2021, which is exempt under Rule 16b-3(c).